Monday, March 14, 2011

Crux Biomedical adds Randy Lindholm to board

Crux Biomedical Inc. put Randy Lindholm on its board of directors.
The Menlo Park company, started in 2004 by Dr. Tom Fogarty, a former professor at Stanford University, makes a medical device called a Vena Cava Filter that traps blood clots that could cause a pulmonary embolism.

No comments:

Post a Comment